HomeMLTX • NASDAQ
add
MoonLake Immunotherapeutics
Previous close
$18.02
Day range
$17.34 - $18.20
Year range
$5.95 - $62.75
Market cap
1.30B USD
Avg Volume
1.29M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 65.22M | 31.54% |
Net income | -62.43M | -36.89% |
Net profit margin | — | — |
Earnings per share | -0.92 | -27.78% |
EBITDA | -64.47M | -30.99% |
Effective tax rate | -0.40% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 393.97M | -12.07% |
Total assets | 424.43M | -11.19% |
Total liabilities | 119.95M | 388.76% |
Total equity | 304.48M | — |
Shares outstanding | 71.73M | — |
Price to book | 4.22 | — |
Return on assets | -38.88% | — |
Return on capital | -43.65% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -62.43M | -36.89% |
Cash from operations | -58.79M | -21.29% |
Cash from investing | -29.91M | 79.70% |
Cash from financing | 72.40M | 47,843.71% |
Net change in cash | -16.22M | 91.69% |
Free cash flow | -37.28M | -8.75% |
About
Founded
2020
Headquarters
Website
Employees
130
